Skip to content
BridgeBio Pharma, Inc. (BBIO) Stock Price, Key Stats & Insider Trading
Home / Companies / BBIO BBI
BridgeBio Pharma, Inc. (BBIO) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest BBIO Insider Trades
About BridgeBio Pharma, Inc. (BBIO) BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
Headquarters PALO ALTO, CA
Employees 839
Listed 2019
Exchange XNAS https://www.bridgebio.com SEC filings for BBIO on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 31 427,343 $33.00M Grant or award 24 111,204 Option exercise 26 720,072
BBIO Insider Transactions (Form 4) 119 93 Form 4 filings on record, the earliest from Nov 19, 2024, newest first. Filing history page 2 of 3.
Date Insider Transaction Security Shares Price Value Mar 18, 2026 TT Thomas Trimarchi - Officer Grant or award Common Stock 59,041
Recent BBIO Form 8-K Filings 5
Recent BBIO Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 19, 2026 KUMAR HALDEA FAMILY IRREVOCABLE TRU/T/A DTD 05/18/2019 Director, Officer 30,000 $2.49M View on EDGAR Aug 18, 2026 NEIL KUMAR Director, Officer
BBIO Insider Trading - FAQ
What is the latest insider trade for BBIO? BridgeBio Pharma, Inc. (BBIO) had 22 insider filings in the last 90 days, with the most recent on 2026-08-20. The full record for BBIO runs to 93 Form 4 filings, the earliest from 2024-11-19. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying BBIO stock? No insider purchases of BBIO were filed in the last 90 days.
How many insiders are selling BBIO stock? 31 insider sales of BBIO were filed in the last 90 days, totaling $33.00M.
Where can I see BBIO SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks BBIO Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow BBIO insider buys? Create a free InsiderAlpha account and press Watch on this page to add BBIO to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track BBIO insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $1.21M
Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $100K
Aug 18, 2026
NK Neil Kumar - Officer Open-market sale $679K
Aug 19, 2026
NK Neil Kumar - Officer Open-market sale $152K
Aug 19, 2026
NK Neil Kumar - Officer Open-market sale $9K
Aug 19, 2026
Market cap $14.97B
P/E ratio -
Dividend yield -
Average volume 3.19M
52 week high $93.42
52 week low $48.78
Today's high $80.55
Today's low $76.34
Open $79.99
Volume 1.96M
Previous close $78.68
Shares outstanding 195.49M Market cap
$14.97B
839 employees
BBIO Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 31 sales totaling $33.00M.
Most-Active BBIO Insiders - Last 90 Days 10 Tax withholding / forfeiture 4 64,520
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Mar 18, 2026 MA Maricel Apuli - Officer Grant or award Common Stock 14,170 $0.00 -
Mar 17, 2026 NK Neil Kumar - Officer Grant or award Stock Option (Right to Buy) 40,570 $0.00 -
Mar 17, 2026 NK Neil Kumar - Officer Grant or award Restricted Stock Units 104,313 $0.00 -
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 14,337 $68.48 $982K
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 5,363 $69.32 $372K
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 300 $70.15 $21K
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 300 $70.15 $21K
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 13,885 $68.47 $951K
Mar 12, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 5,815 $69.29 $403K
Mar 13, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 9,690 $68.36 $662K
Mar 13, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 10,310 $69.20 $713K
Mar 13, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 10,241 $68.39 $700K
Mar 13, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 9,759 $69.23 $676K
Mar 10, 2026 HV Hannah Valantine - Director Option exercise Common Stock 8,671 $27.36 $237K
Mar 10, 2026 HV Hannah Valantine - Director Open-market sale Common Stock 8,671 $72.00 $624K
Mar 10, 2026 HV Hannah Valantine - Director Option exercise Stock Option (Right to Buy) 8,671 $0.00 -
Mar 4, 2026 AE Andrea Ellis - Director Option exercise Common Stock 64,921 $8.45 $549K
Mar 4, 2026 AE Andrea Ellis - Director Open-market sale Common Stock 64,921 $64.87 $4.21M
Mar 4, 2026 AE Andrea Ellis - Director Option exercise Stock Option (right to buy) 64,921 $0.00 -
Feb 27, 2026 HV Hannah Valantine - Director Option exercise Common Stock 25,484 $48.45 $1.23M
Feb 27, 2026 HV Hannah Valantine - Director Option exercise Stock Option (Right to Buy) 25,484 $0.00 -
Feb 27, 2026 HV Hannah Valantine - Director Open-market sale Common Stock 14,584 $67.08 $978K
Feb 27, 2026 HV Hannah Valantine - Director Open-market sale Common Stock 10,900 $67.84 $739K
Feb 26, 2026 MA Maricel Apuli - Officer Open-market sale Common Stock 2,000 $66.00 $132K
Feb 19, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 18,923 $71.03 $1.34M
Feb 19, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 8,528 $72.08 $615K
Feb 19, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 602 $72.80 $44K
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Common Stock 33,544 - -
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Common Stock 19,600 - -
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Common Stock 11,554 - -
Feb 16, 2026 NK Neil Kumar - Officer Tax withholding / forfeiture Common Stock 30,970 $75.25 $2.33M
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Restricted Stock Units 33,544 $0.00 -
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Restricted Stock Units 19,600 $0.00 -
Feb 16, 2026 NK Neil Kumar - Officer Option exercise Restricted Stock Units 11,554 $0.00 -
Feb 16, 2026 MA Maricel Apuli - Officer Tax withholding / forfeiture Common Stock 4,349 $75.25 $327K
Feb 17, 2026 MA Maricel Apuli - Officer Open-market sale Common Stock 510 $74.31 $38K
Feb 16, 2026 TT Thomas Trimarchi - Officer Tax withholding / forfeiture Common Stock 18,819 $75.25 $1.42M
Feb 17, 2026 TT Thomas Trimarchi - Officer Open-market sale Common Stock 13,400 $74.71 $1.00M
Feb 17, 2026 TT Thomas Trimarchi - Officer Open-market sale Common Stock 200 $75.38 $15K
Feb 17, 2026 RS Randal W. Scott - Director Option exercise Common Stock 10,000 $16.75 $168K
Feb 17, 2026 RS Randal W. Scott - Director Open-market sale Common Stock 1,900 $74.34 $141K
Feb 17, 2026 RS Randal W. Scott - Director Open-market sale Common Stock 4,793 $75.57 $362K
Feb 17, 2026 RS Randal W. Scott - Director Open-market sale Common Stock 3,307 $75.93 $251K
Feb 17, 2026 RS Randal W. Scott - Director Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Feb 10, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 5,799 $72.28 $419K
Feb 10, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 14,040 $71.80 $1.01M
Feb 10, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 5,960 $72.27 $431K
Feb 10, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 14,201 $71.80 $1.02M
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 7,806 $70.69 $552K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 3,716 $71.44 $265K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 4,484 $72.64 $326K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 3,994 $73.25 $293K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 7,860 $70.70 $556K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 3,775 $71.46 $270K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 4,404 $72.65 $320K
Feb 11, 2026 NK Neil Kumar - Officer Open-market sale Common Stock 3,961 $73.25 $290K
Dec 12, 2025 NK Neil Kumar - Officer Option exercise Common Stock 60,975 - -
Dec 12, 2025 NK Neil Kumar - Officer Tax withholding / forfeiture Common Stock 30,964 $75.15 $2.33M
Dec 15, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 28,311 $74.60 $2.11M
Dec 15, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 1,700 $75.24 $128K
Dec 12, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 60,975 $0.00 -
Dec 12, 2025 MA Maricel Apuli - Officer Tax withholding / forfeiture Common Stock 2,003 $75.15 $151K
Dec 12, 2025 TT Thomas Trimarchi - Officer Tax withholding / forfeiture Common Stock 13,826 $75.15 $1.04M
Nov 20, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 6,401 $64.97 $416K
Nov 20, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 14,299 $65.90 $942K
Nov 20, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 5,456 $66.71 $364K
Nov 18, 2025 AL Andrew Lo - Director Open-market sale Common Stock 30,993 $66.05 $2.05M
Nov 17, 2025 AL Andrew Lo - Director Open-market sale Common Stock 36,801 $66.63 $2.45M
Nov 17, 2025 AL Andrew Lo - Director Open-market sale Common Stock 3,798 $67.06 $255K
Nov 18, 2025 AL Andrew Lo - Director Open-market sale Common Stock 24,007 $65.23 $1.57M
Nov 17, 2025 RS Randal W. Scott - Director Option exercise Common Stock 10,000 $16.75 $168K
Nov 17, 2025 RS Randal W. Scott - Director Open-market sale Common Stock 3,801 $66.25 $252K
Nov 17, 2025 RS Randal W. Scott - Director Open-market sale Common Stock 6,199 $66.89 $415K
Nov 17, 2025 RS Randal W. Scott - Director Option exercise Stock Option (Right to Buy) 10,000 $0.00 -
Nov 17, 2025 TT Thomas Trimarchi - Officer Open-market sale Common Stock 9,978 $66.19 $660K
Nov 17, 2025 TT Thomas Trimarchi - Officer Open-market sale Common Stock 6,956 $66.84 $465K
Nov 16, 2025 TT Thomas Trimarchi - Officer Tax withholding / forfeiture Common Stock 21,317 $66.39 $1.42M
Nov 16, 2025 MA Maricel Apuli - Officer Tax withholding / forfeiture Common Stock 4,781 $66.39 $317K
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 33,544 $0.00 -
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 19,599 $0.00 -
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Restricted Stock Units 11,554 $0.00 -
Nov 16, 2025 NK Neil Kumar - Officer Tax withholding / forfeiture Common Stock 32,855 $66.39 $2.18M
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Common Stock 33,544 - -
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Common Stock 19,599 - -
Nov 16, 2025 NK Neil Kumar - Officer Option exercise Common Stock 11,554 - -
Nov 12, 2025 HV Hannah Valantine - Director Option exercise Common Stock 25,484 $48.45 $1.23M
Nov 12, 2025 HV Hannah Valantine - Director Open-market sale Common Stock 25,484 $66.07 $1.68M
Nov 12, 2025 HV Hannah Valantine - Director Option exercise Stock Option (Right to Buy) 25,484 $0.00 -
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 100 $64.39 $6K
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 7,371 $63.56 $468K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 12,234 $61.13 $748K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 7,546 $61.87 $467K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 220 $62.79 $14K
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 12,576 $62.91 $791K
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 7,324 $63.55 $465K
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 100 $64.39 $6K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 12,492 $61.14 $764K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 7,308 $61.87 $452K
Nov 7, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 200 $62.81 $13K
Nov 6, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 12,529 $62.91 $788K
Nov 6, 2025 RD Ronald J. Daniels - Director Option exercise Common Stock 61,031 $34.65 $2.11M
Nov 6, 2025 RD Ronald J. Daniels - Director Open-market sale Common Stock 61,031 $63.72 $3.89M
Nov 6, 2025 RD Ronald J. Daniels - Director Option exercise Stock Option (Right to Buy) 61,031 $0.00 -
Oct 29, 2025 FM Frank McCormick - Director Open-market sale Common Stock 3,497 $67.52 $236K
Oct 29, 2025 FM Frank McCormick - Director Open-market sale Common Stock 8,598 $68.50 $589K
Oct 29, 2025 FM Frank McCormick - Director Open-market sale Common Stock 43,393 $69.24 $3.00M
Oct 29, 2025 FM Frank McCormick - Director Open-market sale Common Stock 111,755 $65.48 $7.32M
Oct 29, 2025 FM Frank McCormick - Director Open-market sale Common Stock 31,116 $66.20 $2.06M
Oct 27, 2025 FM Frank McCormick - Director Open-market sale Common Stock 1,641 $65.00 $107K
Oct 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 8,706 $54.39 $474K
Oct 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 11,294 $55.09 $622K
Oct 9, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 20,000 $54.80 $1.10M
Oct 9, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 20,000 $54.80 $1.10M
Oct 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 8,705 $54.39 $473K
Oct 8, 2025 NK Neil Kumar - Officer Open-market sale Common Stock 11,295 $55.09 $622K
Sep 5, 2025 FM Frank McCormick - Director Option exercise Common Stock 74,000 $11.92 $882K
Sep 5, 2025 FM Frank McCormick - Director Open-market sale Common Stock 74,000 $53.16 $3.93M
Sep 5, 2025 FM Frank McCormick - Director Option exercise Stock Option (Right to Buy) 74,000 $0.00 -
